熱門資訊> 正文

ADC Therapeutics申请通过出售股东出售2773万股普通股

2025-07-01 05:36

ADC Therapeutics (NYSE:ADCT) filed a prospectus to sale 27.73 million shares of common stock.
The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder.
This prospectus is not an offer to sell.
Filing

More on ADC Therapeutics

ADC reports data from lymphoma trial, streamlines operations
ADC Therapeutics announces $100M private financing
Seeking Alpha’s Quant Rating on ADC Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。